I'll take a stab at this. I don't think we have had any legit offers. Having listened to many CCs over the past couple years tidbits like NP stating people tell him that we just have miravaroc in injection form because we aren't the first CCR5 antagonist. The binding mechanism is what sets us apart, but BP doesn't care. HIV combo is not a large addressable market (monotherapy is the holy grail). We haven't proven anything through trials in COVID as the primary end points were not met, and we only just started getting decent mtnbc and Nash human data to play out theories that this will work in humans as much as mice. Big pharma doesn't listen to all of the sales pitch CCs and read this board. They have scientists looking at data. So I'd say they don't view us as a threat at all because we've failed to properly file a bla, covid trials, and the big money makers of cancer and Nash are still yet to be determined.

SK has said now that the cancer data is out there, things are heating up. If BTD is granted I would expect.that fire to burn even hotter. Multiple BTDs and we can start naming our price... but until then this is a lottery ticket with high risk/reward chances.